Siân Williams NHS London Respiratory Team Programme Manager Creating a case for a 1% shift Improving value in programme budgets.

Slides:



Advertisements
Similar presentations
Learning from managed care in mental health Dr Richard Ford Director.
Advertisements

Driving improved quality in respiratory care - levers and tools from national policy Bronwen Thompson, Policy adviser to PCRS-UKJune 2013.
Fylde Coast Integrated Diabetes Care
Salford Primary Care Trust – your leader for health IN Salford Salford Primary Care Trust 5-year Strategic Plan 2009 – 2014 Briefing to the Salford Strategic.
Tackling Fuel Poverty Identified as a key priority in JSNA 2008 Tackling Fuel Poverty Identified as a key priority in JSNA 2008 ‘Likely to have the greatest.
The West Cheshire Way Be part of the conversation.. Alison Lee Chief Officer West Cheshire Clinical Commissioning Group Making sure you get the healthcare.
Smoking and mental health Mark Allen Specialist Health Improvement Practitioner.
Nabeela Bari Savitha Pushparajah GP respiratory leads.
Clinical Network for Mental Health. With the exception of London, all the areas with a rate of more than 2,000 years of life lost per 100,000 patients.
Smoking Cessation Ruby Poppleton Health Improvement Specialist.
Coordinating value based care for Londoners with COPD and asthma Dr Louise Restrick, Co-lead LRT Integrated Consultant Respiratory Physician Whittington.
Noel Baxter and Louise Restrick Stop smoking as treatment workstream Stop Smoking as Treatment.
London Respiratory Team Changing lifestyles and improving outcomes: reframing the way we think about smoking Dr Louise Restrick London RespiratoryTeam.
Think Pharmacy Sue Sharpe CEO PSNC. Outline of Talk The Vision for the future community pharmacy The four domains for pharmacy services  Medicines Optimisation.
NHS Southern Derbyshire Clinical Commissioning Group Call to Action Andy Layzell Chief Officer.
1 Integration to avoid hospital admission: ITHAcA Sarah Purdy on behalf of the HIT.
SMOKEFREE Consumer leadership Kaaren Beverley R N, Diploma Counselling Healthy Lifestyle Co-ordinator Buchanan Rehabilitation Centre.
VALUE AND RESPONSIBLE RESPIRATORY PRESCRIBING Dr Vince Mak, Consultant Physician, NWLH Trust.
Satbinder Sanghera, Director of Partnerships and Governance
Respiratory Benchmarking Packs Yorkshire and the Humber September 2010.
London Respiratory Team Understanding respiratory spend and increasing value: Inhalers and nicotine replacement therapy Responsible Respiratory Prescribing.
Planning David Bonson April March-May We are here Final draft of plan.
Smoke free Interventions in Emergency Care Is it working? Is it Appropriate in EC? Vanessa Thornton Clinical Head ED Middlemore Hospital.
Real-world effectiveness of nicotine replacement therapy in pregnancy Leonie S. Brose, PhD Andy McEwen, PhD & Robert West, PhD University College London.
Pacific Nurse Leader and Smoking Cessation Fono
Smoking Cessation Treatment Services in the United Kingdom Hayden McRobbie Barts and The London School of Medicine University of London.
Respiratory Service Framework Asthma and COPD Care (Nursing) Project Learning and Development Strategy.
Wendy Preston Advanced Nurse Practitioner Ambulatory Care Lead Stop Smoking Manager BTS Stop Smoking Champion Senior Lecturer.
Challenges Objectives CCG Led Initiatives Vision ‘How’ Outcome Aspirations Better integrated health and social care Improve the health and wellbeing of.
An Implementation Guide and Toolkit for Making Every Contact Count Making the Case Presentation Trainer notes – the notes accompanying the slides are to.
Group vs. individual therapy – which is best? Andy McEwen CRUK Health Behaviour Unit University College London.
Commissioning the right COPD care for Londoners 7 November 2011 Royal College of Physicians.
Has the Quality and Outcomes Framework resulted in more timely diagnosis of COPD in primary care? LC Hunter, CM Fischbacher, N Hewitt, D McAllister, S.
High Impact Changes. Prioritize alcohol within LAAs and NHS Operating Framework – Vital Signs Improve treatment Review pathways and access – NATMS Evidence.
QIPP initiative analysis: summary by PCT by type – shown cumulatively for impact on gap.
Smokefree interventions in Emergency Care Are they working? Courtney Rouse Smokefree Specialist- Inpatient Services, MMH.
Developing and implementing a new approach to smoking at Kings College Hospital: a joined up approach for South Londoners Dr Irem Patel Consultant Respiratory.
Long Term Conditions Strategy There are 3 key aims to our improvement strategy: WHCCG has already achieved: – Commissioned Diabetes education through the.
Using CQUINS to improve COPD care on discharge from Acute Trust
Presented by Dr. ALASTAIR NOBLE. CLINICAL DECISION = PURCHASING DECISION.
Airways - ICP launch Dr Mike Bewick Deputy Medical Director NHS England 17 Feb 2014.
Responsible Respiratory Prescribing
Respiratory Service Framework Asthma and COPD Care (Nursing) Project Learning and Development Strategy.
Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Primary Care Intelligence A GP Perspective.
Right Care in the right place, human centred care at home and in the community Sally King MSc MCSP NMP Respiratory Specialist Physiotherapist.
1 Maintaining downward pressure on smoking prevalence Robert West University College London All Party Parliamentary Group on Smoking September 2015.
1 Cost efficacy of smoking cessation interventions Robert West University College London Logroño, October
The ‘impossible dream’ Implementing a No Smoking Policy on hospital grounds - Why preventing smoking in the workplace requires more than just policy Trina.
1 Recent studies of clinical significance University College London June 2011 Robert West.
Richard Sekula Head of PH Intelligence NHS Greenwich.
Effectiveness of interventions to aid smoking cessation Robert West University College London September 2008.
Think Pharmacy Sue Sharpe CEO PSNC. Outline of Talk The Vision for the future community pharmacy The four domains for pharmacy services  Medicines Optimisation.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
1 A national initiative to help smokers quit: the English experience Robert West University College London Stockholm, April 2008.
Manchester’s Primary Care Led Prevention Programme Our Approach to a Radical Upgrade in Prevention and Population Health.
Clare Meernik, MPH 1 ; Anna McCullough, MSW, MSPH, CTTS 1 ; Leah Ranney, PhD 1 ; Barbara Walsh 2 ; Adam O. Goldstein, MD, MPH 1 Predictors of Quit for.
Commissioning for value: Mike Ward Winter BTS 2013.
Working for healthier lungs The Whys and Whats of Care Bundles 23 November 2012.
Pulmonary Rehabilitation Primary Care Education Event 23/11/16
Robert West University College London London March 2008
Think Pharmacy Sue Sharpe CEO PSNC.
Medicines Management – COPD update for LPC Jyoti Saini Hema Patel
Behavioural and pharmacological approaches to treating smokers
Tobacco Cessation Guidelines for COPD
Towards a Smokefree Generation: A Tobacco Control Plan for England South West Clinical Senate 21 September 2017
Respiratory Right Care
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
Delivery of the Risky Behaviour CQUIN
COPD in West Essex Dr.Angus Henderson Prof.Mike Roberts
Presentation transcript:

Siân Williams NHS London Respiratory Team Programme Manager Creating a case for a 1% shift Improving value in programme budgets

Imagine we used the value framework Health Outcomes Patient defined bundle of care CostValue = Health Outcomes Cost of delivering Outcomes Porter ME; Lee TH NEJM 2010;363: ;

To invest appropriately in interventions for people with COPD Triple Therapy £35,000- £187,000/QALY LABA £8,000/QALY Tiotropium £7,000/QALY Pulmonary Rehabilitation £2,000-8,000/QALY Stop Smoking Support with pharmacotherapy £2,000/QALY Flu vaccination £1,000/QALY in “at risk” population

Jiminez Ruiz et al Nicotine and Tobacco Research 2011 ~500 smokers with severe COPD Mean age 58 years 60 pack-years of smoking High nicotine dependence 10 intensive behavioral interventions with medication: 233 Nicotine Replacement Therapy & 190 Varenicline 48.5% abstinence at 6 months 61% with Varenicline and 44% with NRT Safe Even those with severe disease

Because even before that paper we knew enough to proceed at a clinical level ‘Offer nicotine replacement therapy, varenicline or bupropion (unless contraindicated) combined with a support programme to optimise quit rates… to all people with COPD who still smoke at every opportunity.’ NICE 2010

J Health Serv Res Policy Jul;16(3): Emergency respiratory admissions: influence of practice, population and hospital factors. Purdy S et al. Academic Unit of Primary Health Care, BristolPurdy S et al. For every 1% increase in prevalence of smoking in your COPD population there is a 1% increase in COPD admission rates For every 1% increase in prevalence of smoking in your asthma population there is a 1% increase in asthma admission rates And at a population level

Either from a zero base, or to add to existing interventions Himelhoch S, Lehman A, Kreyenbuhl J et al. Am J Psychiatry 2004;161: out-patients with SMI 60% current smokers (mean age 44) 23% COPD prevalence (self-reported) Only 36% reported having COPD treatment 147 Medicaid patients with SMI 31% COPD prevalence; 50% as co-morbidity Annual costs for SMI and COPD were 4 x higher 45% (5/11) deaths due to respiratory disease Jones DR, Macias C, Barreira PJ et al Psychiatric Services 2004;55:

And there is still unmet need in primary care eg Southwark dashboard 2013 Prevalence of current smoking where status recorded in last 15 months 1550/3335 = 46.5% COPD smokers in last year receiving evidence based stop smoking support – 17.5%

So what if we reduced smoking prevalence by 1%.....

So what if we did this by shifting resources to where the people are?

Where are the people? Sick smokers in hospital beds Smokers in mental health services In prisons Quietly stoical at home Multiple prescriptions

Would it tackle…. Premature mortality Optimising bed days Waste – human spirit, staff resources, time, prescriptions

Primary care management of tobacco dependence and long term conditions, ongoing, sustained, LES, QOF Supporting sick smokers: CQUIN, NRT, stop smoking champions Fall in children's asthma admissions equivalent to 6802 fewer hospital admissions in 3 years after smoking ban. org/content/earl y/2013/01/15/pe ds abstract … org/content/earl y/2013/01/15/pe ds abstract … rnals.org/content/34/1/37.l onghttp://jpubhealth.oxfordjou rnals.org/content/34/1/37.l ong 200 public health interventions analysed for cost-effectiveness 15% were cost -saving 85% were under 20k per QALY

Martin McShane, NHS CB Lead for Long Term Conditions Care (Domain 2), December 2012 If we had £1200 per person per year, the gearing is: £100 – GP, £200 community, £600 acute, £300 specialist If acute goes up by 4% have to take 24% out of primary or 12% out of community; £300 specialist won’t change! If we had £1200 per person per year, the gearing is: £100 – GP, £200 community, £600 acute, £300 specialist If acute goes up by 4% have to take 24% out of primary or 12% out of community; £300 specialist won’t change! Why shift? It’s all about value….

Programme budget illustrations

Respiratory programme budget

Tariffs (* non-mandatory) 1 st single 1 st multi FU single FU multiNon face to face* SpellTrim- point (days) Respiratory medicine OP COPD or bronchitis with NIV without intubation with CC emergency admission Stop smoking West Midlands ( *) General pop’n no Rx Target ed pop’n no Rx General pop’n with Rx Targeted pop’n with Rx (4 week quitter ) 12 week quitter – verified in primary care

What does 1% look like - in Southwark? 1% of respiratory OP spend £18,940 1% of total respiratory secondary care £136, 090 1% of respiratory primary care prescribing £40, /11 Programme budget –usual caveats about coding

Imagine we shifted some of that to where the people are– eg a mental health stop smoking adviser, or a system-wide education and training programme or a joined up stop smoking service – would we achieve greater value?

Potential Savings 20